⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of York Bioanalytical Solutions (Unilabs) and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
York Bioanalytical Solutions (Unilabs)
↗York, United Kingdom
York Bioanalytical Solutions is a specialist Contract Research Organization (CRO) providing bioanalytical, metabolism, and biomarker services to the global pharmaceutical and biotechnology industries. The company supports drug development from early discovery through to post-marketing, offering expertise in both small and large molecule therapeutics.
Founded in 1999 and headquartered in York, UK, the company operates state-of-the-art laboratory facilities equipped with advanced mass spectrometry and immunoassay technology. In 2008, the company was acquired by the Unilabs Group, a major European diagnostic and laboratory services provider, further expanding its resources and logistical capabilities.
CLASSIFICATION
SIZE & FINANCIALS
Employees:51-200
Founded:1999
Ownership:subsidiary
Status:operating
PIPELINE
Stage:Discovery
Lead Drug Stage:N/A (Service Provider)
Modalities:Small molecule, mAb, Peptides, Proteins
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Unilabs Group
Acquired By:Unilabs Group (2008-05-01)
Key Partnerships:Unilabs Group (Parent), Pharmaceutical and Biotech industry clients
COMPETITION
Position:Niche Player
Competitors:Charles River Laboratories, Covance (Labcorp), Certara, Pharmaron
LINKS
Website:yorkbio.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with York Bioanalytical Solutions (Unilabs). The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.